We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


New Model Unveiled for Studying Fungus Behind Pneumocystis Pneumonia

Scientist holding up a vial.
Credit: iStock.
Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 1 minute

Scientists at Tulane University School of Medicine have developed a promising new model to study a pneumonia-causing fungus that has been notoriously difficult to culture in a lab.

Researchers were able to use precision-cut slices of lung tissue to study Pneumocystis species, a fungus that causes Pneumocystis pneumonia in immunosuppressed patients and children.

This innovation overcomes a major hurdle in fungal research — the difficulty of growing this pathogen outside of a living lung — so scientists can more easily test new drugs to fight the infection. The fungus was recently listed among the top 19 fungal priority pathogens by the World Health Organization.

Want more breaking news?

Subscribe to Technology Networks’ daily newsletter, delivering breaking science news straight to your inbox every day.

Subscribe for FREE

“Pneumocystis is likely the most common fungal pneumonia in children and attempts at culturing the organism have largely not been successful.”

- Dr. Jay Kolls

“Pneumocystis is likely the most common fungal pneumonia in children and attempts at culturing the organism have largely not been successful.” said corresponding author Dr. Jay Kolls, John W Deming Endowed Chair in Internal Medicine at Tulane. “Thus, we have not had new antibiotics in over 20 years as they have to be tested in experimental animal studies.”

The Tulane model utilizes precision-cut lung slices which retain the complexity and architecture of lung tissue, providing an environment that closely mimics conditions inside the lung. The results were published in mBio, the journal of The American Society for Microbiology.

Researchers used tissue from mice to cultivate two forms of the Pneumocystis fungus—the troph and ascus—for up to 14 days. The viability testing and gene expression analysis they conducted showed the fungus survived over time in the model.

“This is the first time both the trophic and ascus forms of Pneumocystis have been maintained long-term outside a mammalian host,” Kolls said.

The researchers confirmed the model’s potential for in vitro drug testing. When treated with commonly used medications trimethoprim-sulfamethoxazole and echinocandins, the expression of Pneumocystis genes was reduced, indicating successful targeting of the fungus.

The Tulane technique reliably generates many uniform lung tissue samples for experimentation from a single lung, enabling high-capacity testing.

“With optimization, we believe precision lung slices could enable actual growth of Pneumocystis and become a powerful tool for developing new medications to treat this infection,” Kolls said. “This could significantly accelerate research on this pathogen.”

Reference: Munyonho FT, Clark RDE, Lin D, et al. Precision-cut lung slices as an ex vivo model to study Pneumocystis murina survival and antimicrobial susceptibility. Heitman J, ed. mBio. 2023:e01464-23. doi: 10.1128/mbio.01464-23

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.